CSNV Stock Overview
AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide.
Snowflake Score | |
---|---|
Valuation | 3/6 |
Future Growth | 1/6 |
Past Performance | 2/6 |
Financial Health | 3/6 |
Dividends | 4/6 |
AXA SA Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | €32.63 |
52 Week High | €32.95 |
52 Week Low | €27.00 |
Beta | 1.24 |
1 Month Change | 10.24% |
3 Month Change | n/a |
1 Year Change | n/a |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | 10.65% |
Recent News & Updates
Recent updates
Shareholder Returns
CSNV | FR Insurance | FR Market | |
---|---|---|---|
7D | 2.6% | 2.3% | 0.9% |
1Y | n/a | 25.6% | 10.6% |
Return vs Industry: Insufficient data to determine how CSNV performed against the French Insurance industry.
Return vs Market: Insufficient data to determine how CSNV performed against the French Market.
Price Volatility
CSNV volatility | |
---|---|
CSNV Average Weekly Movement | 3.7% |
Insurance Industry Average Movement | 3.0% |
Market Average Movement | 4.2% |
10% most volatile stocks in FR Market | 10.1% |
10% least volatile stocks in FR Market | 2.2% |
Stable Share Price: CSNV has not had significant price volatility in the past 3 months.
Volatility Over Time: Insufficient data to determine CSNV's volatility change over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1852 | 92,695 | Thomas Buberl | https://www.axa.com |
AXA SA, through its subsidiaries, provides insurance, asset management, and banking services worldwide. The company operates through six segments: France, Europe, Asia, AXA XL, International, and Transversal & Central Holdings. It offers life and savings insurance products, such as savings and retirement, other health, and personal protection products.
AXA SA Fundamentals Summary
CSNV fundamental statistics | |
---|---|
Market cap | €76.17b |
Earnings (TTM) | €6.47b |
Revenue (TTM) | €102.01b |
11.8x
P/E Ratio0.7x
P/S RatioIs CSNV overvalued?
See Fair Value and valuation analysisEarnings & Revenue
CSNV income statement (TTM) | |
---|---|
Revenue | €102.01b |
Cost of Revenue | €82.76b |
Gross Profit | €19.25b |
Other Expenses | €12.78b |
Earnings | €6.47b |
Last Reported Earnings
Jun 30, 2023
Next Earnings Date
May 02, 2024
Earnings per share (EPS) | 2.94 |
Gross Margin | 18.87% |
Net Profit Margin | 6.35% |
Debt/Equity Ratio | 105.0% |
How did CSNV perform over the long term?
See historical performance and comparison